FOXC1 and colorectal carcinoma: In a genetic epistasis analysis, it was observed that when FOXC1 binds to ITGA7 and FGFR4, its expression is increased in metastatic CRC cells, and therefore FGFR4 has been proposed as a potential drug target [40].